Search

Search Constraints

You searched for: Author/Creator Nussbaumer, Peter

Search Results

1. Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action. (24th April 2019)

2. Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding Site. Issue 25 (3rd November 2016)

3. Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein. Issue 4 (19th April 2018)

4. Identification of an (−)‐englerin A analogue, which antagonizes (−)‐englerin A at TRPC1/4/5 channels. (25th January 2018)

5. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. (16th October 2017)

7. Na+ entry through heteromeric TRPC4/C1 channels mediates (−)Englerin A-induced cytotoxicity in synovial sarcoma cells. Issue 1 (December 2017)